Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 8Leukemia, Myelomonocytic, Chronic 6Triple Negative Breast Neoplasms 2Systemic Mastocytosis With an Associated Hematologic Neoplasm 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neuroendocrine Tumors 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1GATA2 Deficiency 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1BRCA1 Mutation 1

Interventions

Cytarabine 13Cyclophosphamide 11fludarabine 10Filgrastim 8fludarabine phosphate 7Methotrexate 7Vincristine 6Specimen Handling 5Dexamethasone 5Biopsy 5venetoclax 4revumenib 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Azacitidine 4Whole-Body Irradiation 3Prednisone 3Mycophenolic Acid 3Leucovorin 3Hydrocortisone 3Clofarabine 3selinexor 2merphos 2ixazomib 2blinatumomab 2aldesleukin 2X-Rays 2Vorinostat 2Topotecan 2Thiotepa 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Biphenotypic, Acute × decitabine and cedazuridine drug combination × Clear all
NCT04980404 2026-03-30

Inqovi Maintenance Therapy in Myeloid Neoplasms

Massachusetts General Hospital

Phase 1 Active not recruiting
22 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡